Intra-Cellular Therapies, Inc. (ITCI)


Stock Price Forecast

April 26, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Intra-Cellular Therapies, Inc. chart...

About the Company

We do not have any company description for Intra-Cellular Therapies, Inc. at the moment.

Sector

Life Sciences

Industry

Pharmaceutical Preparations

Employees

514

Exchange

Nasdaq

$268M

Total Revenue

514

Employees

$7B

Market Capitalization

-40.27

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $ITCI News

The Analyst Verdict: Intra-Cellular Therapies In The Eyes Of 14 Experts

6d ago, source:

In the assessment of 12-month price targets, analysts unveil insights for Intra-Cellular Therapies, presenting an average ...

Intra-Cellular Therapies Prices Public Offering of Common Stock

11d ago, source:

Inc. (Nasdaq: ITCI) (“Intra-Cellular Therapies”), a biopharmaceutical company focused on the development and ...

Intra-Cellular Stock Rallies On Successful Late-Stage Depression Treatment Study

on MSN ago, source:

Intra-Cellular Therapies Inc (NASDAQ:ITCI) unveiled on Tuesday topline results from Study 501 evaluating lumateperone 42 mg ...

Intra-Cellular (ITCI) Up as Depression Drug Meets Study Goals

11d ago, source: Zacks.com on MSN

Intra-Cellular Therapies, Inc. ITCI announced positive top-line results from its late-stage study evaluating lumateperone 42 ...

Why Intra-Cellular Therapies Is Rising In Pre-market?

12d ago, source:

Intra-Cellular Therapies, Inc. (ITCI) reported positive topline results from Study 501 evaluating lumateperone 42 mg as an adjunctive ...

Intra-Cellular: More Upside Possible Even After Positive MDD Treatment Data

12d ago, source:

Positive results from two Intra-Cellular Therapies phase 3 studies show lumateperone's potential as adjunctive therapy for ...

Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock

12d ago, source:

Intra-Cellular Therapies, Inc. (Nasdaq: ITCI) (“Intra-Cellular Therapies”), a biopharmaceutical company focused on the ...

Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock

12d ago, source: Nasdaq

NEW YORK, April 16, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI) (“Intra-Cellular Therapies”), a biopharmaceutical company focused on the development and ...

Intra-Cellular Therapies Prices Public Offering of Common Stock

11d ago, source: WDAF-TV

NEW YORK, April 17, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI) (“Intra-Cellular Therapies”), a biopharmaceutical company focused on the development and ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...